Co-Authors
This is a "connection" page, showing publications co-authored by Oliver Cornely and Maria Vehreschild.
Connection Strength
1.065
-
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses. Eur J Clin Microbiol Infect Dis. 2019 Jun; 38(6):1187-1194.
Score: 0.204
-
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScopeĀ®. Crit Rev Microbiol. 2019 Feb; 45(1):1-21.
Score: 0.201
-
Chlorhexidine-containing dressings in the prevention of central venous catheter-related bloodstream infections: A cost and resource utilization analysis. Am J Infect Control. 2018 09; 46(9):992-997.
Score: 0.191
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia. J Antimicrob Chemother. 2017 08 01; 72(8):2359-2367.
Score: 0.182
-
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19. Immunity. 2020 12 15; 53(6):1258-1271.e5.
Score: 0.057
-
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). J Antimicrob Chemother. 2019 11 01; 74(11):3315-3327.
Score: 0.053
-
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. Lancet Infect Dis. 2018 03; 18(3):296-307.
Score: 0.047
-
FungiScopeā¢ -Global Emerging Fungal Infection Registry. Mycoses. 2017 Aug; 60(8):508-516.
Score: 0.045
-
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry. Mycoses. 2017 Apr; 60(4):273-279.
Score: 0.044
-
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016 Jul; 16(7):828-837.
Score: 0.041